Tranzyme completes drug discovery partnership with Bristol-Myers

Tranzyme Pharma has completed the chemistry-based drug discovery partnership and transferred the resulting compounds to Bristol-Myers Squibb to advance the development.

---

Bristol-Myers Squibb Company to Announce Results for Fourth Quarter, Full Year 2012 on January 24

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter and full year of 2012 on Thursday, January 24, 2013. During a conference call at 10:30 a.m. ET on January 24, compa…

---

Tranzyme Pharma Could be in for Big Paydays From Drug Giant Bristol-Myers Squibb Company

RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule macrocycl…

---

Bristol-Pfizer’s blood thinner Eliquis wins FDA approval

Bristol-Myers Squibb and Pfizer's Eliquis, or apixaban, has been approved by the FDA to reduce the risk of strokes and blood  -More- …

---